← Back to all trials
Not Yet Recruiting
NCT05601583
Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment
Conditions: Type 2 Diabetes, Mild Cognitive Impairment
Sex: All
Ages: 65 Years – 100 Years
Phase: PHASE1
Enrollment: 20
Sponsor: NYU Langone Health
Location: United States
Summary
Eligible older adults with Type 2 Diabetes-Mild Cognitive Impairment (T2D-MCI) will be provided a Continuous Glucose Monitoring (CGM) device and asked to share CGM data with their care partners for daily decision-making for diabetes self-management.
After 2 weeks, individual interviews will be conducted in 20 participants (10 dyads).
Older adults with T2D-MCI (n=10) and their care partners (n=10) will be interviewed separately to identify key features of the Care Partner-Assisted Intervention through linking continuous glucose monitoring and Mobile Health (CP-CGMH) app.
Eligibility Criteria
Inclusion Criteria:Older adults must meet all of the following criteria:be ≥ 65 years old;have had a diagnosis of T2D for at least one year;have MCI, defined as score 19-25 on the Montreal Cognitive Assessment (MoCA);60,61have a care partner (e.g., spouse or adult children);be willing to use CGM;be fluent in English.Eligible care partners must be:≥ 18 years old;living with older adults with T2D-MCI;willing to be involved in patients' daily care;fluent in English.Exclusion Criteria:Older adults who meet any of the following criteria will be excluded from participation in this study:Refuse or are unable to provide informed consent;Have serious physical illness (e.g., end-stage renal disease);Presence of mental illness (e.g., schizophrenia or bipolar disorder) that would preclude participation.The care partners will be excluded if they:Refuse or are unable to provide informed consent;Have MCI.
Source: ClinicalTrials.gov (NCT05601583). StuddyBuddy aggregates publicly available trial information.